Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
🚨 Our Pro Data Reveals the True Winner of Earnings Season Access Data
Close

GSK plc (GS71)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
16.380 +0.060    +0.37%
31/01 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 84,329
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 16.160 - 16.480
Type:  Equity
Market:  Germany
ISIN:  GB00BN7SWP63 
WKN:  A3DMB5
GSK plc 16.380 +0.060 +0.37%

GS71 Income Statement

 
Assess the Glaxo income statement, view the company's financial performance across their assets and liabilities. Select to view either quarterly or annual data.
AnnualQuarterly
InvestingPro Advanced Income Statement
Collapse All
Period Ending: 2022
30/09
 2022
30/06
 2022
31/03
 2021
31/12
Total Revenue 7829 6929 7190 -
Revenue 7829 6929 7190 -
Other Revenue, Total - - - -
Cost of Revenue, Total 2386 2145 2690 -
Gross Profit 5443 4784 4500 -
Total Operating Expenses 5468 5220 5482 -
Selling/General/Admin. Expenses, Total 2014 1960 1783 -
Research & Development 1323 1180 1112 -
Depreciation / Amortization 758 - 507 -
Interest Expense (Income) - Net Operating -199 -204 -205 -
Unusual Expense (Income) - - - -
Other Operating Expenses, Total -814 139 -405 -
Operating Income 2361 1709 1708 -
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets - - - -
Other, Net 1349 813 -386 -
Net Income Before Taxes 1012 896 2094 -
Provision for Income Taxes 233 150 323 -
Net Income After Taxes 779 746 1771 -
Minority Interest -436 6266 6451 6287
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 759 706 1496 -
Total Extraordinary Items 9556 132 306 -
Net Income 10315 838 1802 -
Total Adjustments to Net Income -9556 -132 -306 -
Income Available to Common Excluding Extraordinary Items 759 706 1496 -
Dilution Adjustment 9554.63 130.86 305.1 -
Diluted Net Income 760.37 707.14 1496.9 -
Diluted Weighted Average Shares 4088 4064 4054 -
Diluted EPS Excluding Extraordinary Items 0.186 0.174 0.369 -
DPS - Common Stock Primary Issue 0.138 0.162 0.175 -
Diluted Normalized EPS 0.329 0.225 0.165 -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

GSK Comments

Write your thoughts about GSK plc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
John Ford
John Ford Jan 24, 2023 15:53
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
All export earners today are going south
Reply
0 0
Report
Dan Morris
Dan Morris Dec 07, 2022 13:23
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Lovely little boost from the Zantec case today. Let's hope the shares kick onwards from here
Reply
2 0
Report
איציק צארלי
איציק צארלי Nov 28, 2022 16:10
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
ITH stock
Reply
1 0
Report
Anon Anon
Anon Anon Nov 11, 2022 16:51
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Bought back all the gsk that I sold back in May. It's a no brainer at this price
Reply
6 0
Report
Anon Anon
Anon Anon Nov 11, 2022 16:51
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Buying GSK is like investing in a junk bond. One need to buy when the yield is high
Reply
0 0
Report
Mike Bamber
Mike Bamber Nov 11, 2022 16:51
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
. Well, yield is OK as long as it's not offset by value destruction through capital loss. In GSKs case as long as Walmsley is at the helm you can guarantee value destruction. She couldn't develop a blockbuster drug or vaccine if her life depended on it. Pascal Sorrel at Astra Zenrcca must be laughing his head off at this train crash of a CEO
Reply
1 0
Report
Anon Anon
Anon Anon Nov 11, 2022 16:51
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
You are right. Also the price has been range bound for a decade and we are now near to the lower bound. I've heard similar comments to you nearly ever year when it's price is underperforming
Reply
0 0
Report
Mike Bamber
Mike Bamber Nov 11, 2022 16:51
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I wish the institutional shareholders would wake up and do something about the management team. Surely with such an abysmal performance over so long GSK must be a takeover target?
Reply
0 0
Report
Anon Anon
Anon Anon Nov 11, 2022 16:51
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I'm only interested in swing trading this counter. If the price doesn't move I'll just collect dividends while waiting for it to bounce. The spinoff of Haleon is a good move as in this day and age companies need to be pure play to get ahead of competition. Consumer healthcare business was a distraction to their management.
Reply
0 0
Report
John Hamilton
John Hamilton Nov 11, 2022 12:15
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
new management required
Reply
2 0
Report
John Williams
John Williams Sep 08, 2022 14:10
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Bloodbath coming
Reply
0 3
Report
Ozkan Gokmenoglu
Ozkan Gokmenoglu Sep 08, 2022 14:10
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Hi John, it will be worsth ?
Reply
0 0
Report
Alun Benjamin
Alun Benjamin Sep 08, 2022 14:10
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
When will this carnage start, exacty (02/11/22)
Reply
0 0
Report
Jenny Gough
Jenny Gough Aug 11, 2022 11:43
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Should have taken the Unilever offer...
Reply
9 0
Report
Mark Olive
magicpiano Aug 11, 2022 11:43
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
It was madness not to.
Reply
2 0
Report
Mike Bamber
Mike Bamber Jul 18, 2022 16:06
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Demerger yet another damp squib in a long line of failures by Walmsley. She is unprecedented in her ability to talk the talk but to not walk the walk!
Reply
9 2
Report
Anon Anon
Anon Anon Jan 17, 2022 11:43
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This may go up further but I've started to take some profit as precaution. I suspect ulvr may not revise their offer after its sp tanking showing clear sentiments from shareholding to reject this move
Reply
2 2
Report
Anon Anon
Anon Anon Dec 09, 2021 8:46
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Moving closer to my 1800 tgt (posted on March 30). This stock pays very generous dividend I have to say
Reply
6 4
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email